Abstract
The present study deciphers the formulation of Quercetin (QRN) loaded nanoemulsion (NE). The nanoemulsion was prepared by using Labrafil M 1944CS as oil phase, Labrafac PG as surfactant, Transcutol P as co-surfactant. The composition was optimized by applying three-level central composite design. The optimized formulation showed droplet size of 41.22 ± 6.38 nm, zeta potential was − 38.52 ± 5.16 mV and drug loading were 87.67 ± 3.32%. The results of dissolution, permeability and oral bioavailability showed about 11.70 folds, 3.44 folds and 28.29 folds, respectively in case of NE-QRN as compared to its naïve form. The results of particle size, zeta potential, and drug loading showed a non-significant change in the response of fresh and aged NE, which indicated that the formulation was stable. The outcomes of successful development of NE-QRN with enhanced bioavailability profile indicated towards possibility to explore this formulation for pharmacodynamic assessment of oxidative stress based metabolic diseases. In vitro results on H9C2 cell line indicated lower cellular proliferation rate after treatment with NE-QRN with decreased cytoplasmic expression of Ace protein. The NE was stable at accelerated stability conditions. Overall results indicated successful development of NE-QRN.
Similar content being viewed by others
Data Availability
Not Applicable.
References
P. S. Sandhu, S. Beg, R. Kumar, O. Katare, and B. Singh (2017). J. Liq. Chromatogr. Relat. Technol. 40, 506.
M. Lesjak, I. Beara, N. Simin, D. Pintać, T. Majkic, K. Bekvalac, D. Orčić, and N. Mimica-Dukić (2018). J. Funct. Foods 40, 68.
Q. Ou, Z. Zheng, Y. Zhao, and W. Lin (2020). Int. J. Food Sci. Nutr. 71, 152.
R. Khursheed, S. K. Singh, S. Wadhwa, M. Gulati, and A. Awasthi (2020). Drug Discov. Today 25, 209.
S. Pathak, S. Regmi, T. T. Nguyen, B. Gupta, M. Gautam, C. S. Yong, J. O. Kim, Y. Son, J.-R. Kim, and M. H. Park (2018). Acta Biomater. 75, 287.
E. Ahmadian, A. Eftekhari, T. Kavetskyy, A. Y. Khosroushahi, V. A. Turksoy, and R. Khalilov (2020). Nanomedicine 167, 104586.
L. Talarico, M. Consumi, G. Leone, G. Tamasi, and A. Magnani (2021). Molecules 26, 2694.
S. Saha, J. Kundu, R. J. Verma, and P. K. Chowdhury (2020). Materialia 9, 100605.
D. J. McClements, E. A. Decker, and J. Weiss (2007). J. Food Sci. 72, R109.
R. Khursheed, S. K. Singh, S. Wadhwa, M. Gulati, B. Kapoor, S. K. Jain, K. Gowthamarajan, F. Zacconi, D. K. Chellappan, and G. Gupta (2021). Int. J. Biol. Macromol. 189, 744.
A. K. Ramanunny, S. Wadhwa, M. Gulati, S. K. Singh, B. Kapoor, H. Dureja, D. K. Chellappan, K. Anand, K. Dua, and R. Khursheed (2021). Eur. J. Pharmacol. 890, 173691.
A. K. Ramanunny, S. Wadhwa, S. Kumar Singh, B. Kumar, M. Gulati, A. Kumar, S. Almawash, A. Al-Saqr, K. Gowthamarajan, K. Dua, H. Singh, S. Vishwas, R. Khursheed, S. Rahana Parveen, A. Venkatesan, K. R. Paudel, P. M. Hansbro, and D. Kumar Chellappan (2022). Int J Pharm. https://doi.org/10.1016/j.ijpharm.2022.121882.
A. H. Saberi, Y. Fang, and D. J. McClements (2013). J.Colloid Interface Sci. 391, 95–102.
F. Kesisoglou, S. Panmai, and Y. Wu (2007). Adv. Drug Deliv. Rev. 59, 631.
N. K. Pandey, S. K. Singh, M. Gulati, B. Kumar, B. Kapoor, D. Ghosh, R. Kumar, R. Khursheed, A. Awasthi, and G. Kuppusamy (2020). J. Drug Deliv. Sci. Technol. 60, 102083.
K. V. Mahesh, S. K. Singh, and M. Gulati (2014). Powder Technol. 256, 436.
S. Som, S. K. Singh, G. L. Khatik, B. Kapoor, M. Gulati, G. Kuppusamy, N. K. Anandhakrishnan, B. Kumar, A. K. Yadav, and R. Kumar (2020). Assay Drug Dev. Technol. 18, 11.
R. Khursheed, S. K. Singh, S. Wadhwa, M. Gulati, A. Awasthi, R. Kumar, A. K. Ramanunny, B. Kapoor, P. Kumar, and L. Corrie (2020). Carbohydr. Polym. 250, 116996.
P. Sharma, S. K. Singh, N. K. Pandey, S. Y. Rajesh, P. Bawa, B. Kumar, M. Gulati, S. Singh, S. Verma, and A. K. Yadav (2018). Powder Technol. 338, 836.
S. Y. Rajesh, S. K. Singh, N. K. Pandey, P. Sharma, P. Bawa, B. Kumar, M. Gulati, S. K. Jain, K. Gowthamarajan, and S. Singh (2018). Drug Dev. Ind. Pharm. 44, 1056.
N. Chandrasekaran (2015). Asian J. Pharm. 9, 23.
S. Shafiq, F. Shakeel, S. Talegaonkar, F. J. Ahmad, R. K. Khar, and M. Ali (2007). Eur. J. Pharm. Biopharm. 66, 227.
B. Kumar, V. Garg, S. Singh, N. K. Pandey, A. Bhatia, T. Prakash, M. Gulati, and S. K. Singh (2018). Powder Technol. 326, 425.
V. Garg, P. Kaur, S. K. Singh, B. Kumar, P. Bawa, M. Gulati, and A. K. Yadav (2017). Eur. J. Pharm. Sci. 109, 297.
S. Zhang, Z. Xie, M. Xu, and L. Shi (2015). Pharm. Biol. 53, 1352.
R. Khursheed, S. K. Singh, B. Kumar, S. Wadhwa, M. Gulati, A. Anupriya, A. Awasthi, S. Vishwas, J. Kaur, and L. Corrie (2021). Int. J. Pharm. 612, 121306.
A. Sharma, B. Kumar, S. K. Singh, M. Gulati, Y. Vaidya, H. Rathee, D. Ghai, A. H. Malik, A. K. Yadav, and P. Maharshi (2018). Curr. Drug Deliv. 15, 367.
R. Kumar, R. Khursheed, R. Kumar, A. Awasthi, N. Sharma, S. Khurana, B. Kapoor, N. Khurana, S. K. Singh, and K. Gowthamarajan (2019). J. Drug Deliv. Sci. Technol. 54, 101252.
N. K. Pandey, S. K. Singh, B. Kumar, M. Gulati, S. Vishwas, R. Khursheed, H. Dureja, D. K. Chellappan, N. K. Jha, A. Sharma, S. K. Jha, P. K. Gupta, S. Gupta, G. Gupta, P. Prasher, and K. Dua (2022). Environ Sci Pollut Res Int. https://doi.org/10.1007/s11356-022-19371-z.
G. Kaur, S. K. Singh, R. Kumar, B. Kumar, Y. Kumari, M. Gulati, N. K. Pandey, K. Gowthamarajan, D. Ghosh, and A. Clarisse (2020). J. Drug Deliv. Sci. Technol. 60, 101980.
Y. Kumari, S. K. Singh, R. Kumar, B. Kumar, G. Kaur, M. Gulati, D. Tewari, K. Gowthamarajan, V. V. S. N. R. Karri, and C. Ayinkamiye (2020). Int. J. Biol. Macromol. 149, 976.
J. Jyoti, N. K. Anandhakrishnan, S. K. Singh, B. Kumar, M. Gulati, K. Gowthamarajan, R. Kumar, A. K. Yadav, B. Kapoor, and N. K. Pandey (2019). Drug Deliv. Transl. Res. 9, 848.
D. Ghosh, S. K. Singh, R. Khursheed, N. K. Pandey, B. Kumar, R. Kumar, Y. Kumari, G. Kaur, A. Clarisse, and A. Awasthi (2020). Drug Dev. Ind. Pharm. 46, 597.
Acknowledgements
The authors are thankful to KIET college of Pharmacy for providing necessary facilities.
Funding
This article was not funded.
Author information
Authors and Affiliations
Contributions
NA: Methodology, Data Curation and Writing—original draft. VK: Conceptualization, Validation, Supervision and Writing—review & editing.
Corresponding author
Ethics declarations
Conflict of interest
Declared None.
Ethical Approval and Consent to Participate
The study protocol was approved by Institutional Animal Ethics Committee (IAEC) of KIET School of Pharmacy with approval no IAEC/KSOP/2021-22/05 before beginning of the experiment.
Consent for Publication
Yes.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Alsabeelah, N., Kumar, V. Formulation and Optimization of Quercetin Nanoemulsion for Enhancing Its Dissolution Rate, Bioavailability and Cardioprotective Activity. J Clust Sci 34, 1893–1906 (2023). https://doi.org/10.1007/s10876-022-02351-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10876-022-02351-1